- To provide tools to monitor the development of health technologies and to share data and results of this monitoring. Only aggregated or anonymised data will be used
- To structure prioritisation for HTA and provide health care decision makers with policy relevant information on new and emerging technologies.
- A tool to monitor emerging technologies in clinical practice with insufficient evidence of clinical or cost effectiveness
- A structured information service on high volume, costly, rapidly developing, emerging technology Strand B, closely coordinated with WP2 and WP6.
AETSA, ASSR, AVALIA-T, Cochrane Collaboration, UK, DHMA, HIQA, AETS-ISCIII, Lübeck University, Germany, NIJZ, Osteba, Veneto/CRUF, SBU, UCSC, University of Bremen, Germany, UTA, ZIN